- Home
- MNKD vs ICHR Comparison
MNKD vs ICHR Comparison
Compare MNKD & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | ICHR |
|---|---|---|
| Founded | 1991 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2004 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MNKD | ICHR |
|---|---|---|
| Price | $2.35 | $46.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $8.64 | ★ $45.67 |
| AVG Volume (30 Days) | ★ 8.0M | 655.6K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | $348,966,000.00 | ★ $947,652,000.00 |
| Revenue This Year | $35.81 | $19.98 |
| Revenue Next Year | $11.89 | $15.92 |
| P/E Ratio | $114.00 | ★ N/A |
| Revenue Growth | ★ 22.23 | 11.61 |
| 52 Week Low | $2.25 | $13.15 |
| 52 Week High | $6.51 | $55.00 |
Technical Indicators
Market Signals| Indicator | MNKD | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 21.52 | 51.38 |
| Support Level | N/A | $15.74 |
| Resistance Level | $6.18 | $55.00 |
| Average True Range (ATR) | 0.14 | 3.45 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 17.19 | 51.03 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About ICHR Ichor Holdings
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.